21 May 2020
Rutherford Health plc
Rutherford Health PLC Agreement with NHS SBS
Rutherford Health plc (the "Company" or "Group" or "Rutherford") is delighted to announce that it has entered into a framework agreement with NHS Shared Business Services ("NHS SBS"), under which it is able to provide cancer treatment services on demand by any NHS Trust at a pre-agreed set of prices. The agreement lasts for two years with an option to extend for a further two years on the agreement of both parties. The agreement covers the complete range of services that Rutherford offers, including radiotherapy, systemic anti-cancer therapy (chemotherapy), proton beam therapy and diagnostic services.
NHS SBS was established by the Department of Health and Social Care (DHSC) in a unique partnership with digital experts Sopra Steria. NHS SBS delivers modern corporate services to the NHS, which improve efficiency and quality, save time and money, and support world-class patient care. Further information about NHS SBS can be found at https://www.sbs.nhs.uk/ .
Mike Moran, Rutherford's CEO commented: "We are absolutely delighted to have signed this agreement with NHS SBS. We have been supplying radiotherapy and systemic anti-cancer therapy to NHS patients in England and Wales and proton beam therapy to a small number of adult NHS patients in Wales under contracts with individual NHS Trusts. This agreement streamlines the procurement process and enables any NHS Trusts in England and Wales to order services directly from us. It means that we are now in a position to expand the services we actually provide.
"I am particularly delighted to be supporting the fantastic work that the NHS are doing at this incredibly difficult time by providing these critically needed cancer treatments and services in dedicated cancer treatment facilities, relieving the pressure on NHS hospitals".
Phil Davies, Director of Procurement at NHS commented: "NHS organisations routinely acquire extra clinical capacity to deal with spikes in demand and to keep waiting lists down for patients. The recent extreme pressure on NHS services means that additional clinical support is likely to be needed now more than ever. We have worked with a number of NHS trusts to put a framework in place that enables any NHS provider to access high-quality clinical services quickly - in a cost-effective and compliant manner."
The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
The directors of Rutherford Health plc accept responsibility for this announcement.